347 related articles for article (PubMed ID: 25201784)
1. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
[TBL] [Abstract][Full Text] [Related]
2. Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index.
Hall A; Mattila J; Koikkalainen J; Lötjonen J; Wolz R; Scheltens P; Frisoni G; Tsolaki M; Nobili F; Freund-Levi Y; Minthon L; Frölich L; Hampel H; Visser PJ; Soininen H
Curr Alzheimer Res; 2015; 12(1):69-79. PubMed ID: 25523428
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
[TBL] [Abstract][Full Text] [Related]
4. Comparing predictors of conversion to Alzheimer's disease using the disease state index.
Muñoz-Ruiz MÁ; Hall A; Mattila J; Koikkalainen J; Herukka SK; Vanninen R; Liu Y; Lötjönen J; Soininen H;
Neurodegener Dis; 2014; 13(2-3):200-2. PubMed ID: 23969422
[TBL] [Abstract][Full Text] [Related]
5. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Dukart J; Sambataro F; Bertolino A
J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
[TBL] [Abstract][Full Text] [Related]
6. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
7. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
8. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
[TBL] [Abstract][Full Text] [Related]
9. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
10. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
Morgen K; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
J Alzheimers Dis; 2013; 37(2):389-401. PubMed ID: 23948881
[TBL] [Abstract][Full Text] [Related]
11. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
[TBL] [Abstract][Full Text] [Related]
12. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
13. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
[TBL] [Abstract][Full Text] [Related]
14. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
[TBL] [Abstract][Full Text] [Related]
15. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
[TBL] [Abstract][Full Text] [Related]
16. Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment.
Aguilar C; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kloszewska I; Soininen H; Lovestone S; Spenger C; Simmons A; Wahlund LO
Psychiatry Res; 2013 May; 212(2):89-98. PubMed ID: 23541334
[TBL] [Abstract][Full Text] [Related]
17. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment.
Spulber G; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Wahlund LO; Westman E;
J Intern Med; 2013 Apr; 273(4):396-409. PubMed ID: 23278858
[TBL] [Abstract][Full Text] [Related]
18. Disease state fingerprint in frontotemporal degeneration with reference to Alzheimer's disease and mild cognitive impairment.
Muñoz-Ruiz MÁ; Hartikainen P; Hall A; Mattila J; Koikkalainen J; Herukka SK; Julkunen V; Vanninen R; Liu Y; Lötjönen J; Soininen H
J Alzheimers Dis; 2013; 35(4):727-39. PubMed ID: 23455991
[TBL] [Abstract][Full Text] [Related]
19. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
[TBL] [Abstract][Full Text] [Related]
20. Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
Rhodius-Meester HF; Koikkalainen J; Mattila J; Teunissen CE; Barkhof F; Lemstra AW; Scheltens P; Lötjönen J; van der Flier WM
J Alzheimers Dis; 2016; 50(1):261-70. PubMed ID: 26577521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]